cell pharm GmbH Company Profile

13:44 EST 23rd November 2014 | BioPortfolio



Email: info@cellpharm.com

News Articles [1617 Associated News Articles listed on BioPortfolio]

Pharm Exec's Pharma 50 2014

For those companies in this year's Pharm Exec Top 50, meeting the accelerating market demand for specialty products has become an acute strategic imperative.


ReferenceSG140612OTHR83Z5Message ReferenceI5UB5EBFDQE31WU8IssuerNameTIANJIN ZHONG XIN PHARM GROUPStatusActiveCountry of IncorporationCNCompany Registration NumberJinQi No.9163201Issuer AddressZhong...


ReferenceSG140612OTHR0G7AMessage ReferenceX51J3RFKR40MJAZFIssuerNameTIANJIN ZHONG XIN PHARM GROUPStatusActiveCountry of IncorporationCNCompany Registration NumberJinQi No.9163201Issuer AddressZhong...

Pharm Exec's 2014 Dealmakers Outlook

As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead for M&A, licensing, ...

Yungjin Pharm Ind. Co., Ltd. - Product Pipeline Review - 2014

Yungjin Pharm Ind. Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Yungjin Pharm Ind. Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the Yungji...

Only fools Rush in: Putin’s Pharma2020 plan unclear says R-Pharm CEO

Government efforts to cut reliance on imports and encourage Big Pharma and local drugmakers to invest in Russian plants are hindered by a lack of clear definitions, says the CEO of R-Pharm.

Cho-A-Pharm’s multi-year sponsorship agreement with Manchester United

In the midst of World Cup fever, Korean pharmaceutical company Cho-A-Pharm was today confirmed in a multi-year sponsorship deal with Manchester United. Cho-A-Pharm makes over 200 products including nu...

PAION: Erweiterung der Lizenzvereinbarung mit R-Pharm - Aktiennews

Aachen - Das Specialty Pharma Unternehmen PAION AG (ISIN: DE000A0B65S3, WKN: A0B65S, Ticker-Symbol: PA8, NASDAQ OTC-Symbol: PAIOF) und R-Pharm, Russland, geben bekannt, dass sie ihre Lizenzabkommen...

PubMed Articles [3126 Associated PubMed Articles listed on BioPortfolio]

To Conduct Clinical Trial in China, To Go or Not To Go.

In last 10 years, more and more clinical trials have come to China because of potential market/easy access of patient and cost-effectiveness, but looking back, there is less change on the regulatory r...

Erratum to "Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy" Sci Pharm. 2013; 81: 843-854.

This is an erratum to the article 'Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy' [Sci Pharm. 2013; 81: 843-854]. Figures 1-3 are added.[This corrects the article on p. 843 in vol...

Exercise Prescription: Who Is the Pharm D?

Cover picture: arch. Pharm. Chem. Life sci. (2/2014).

Editorial board: arch. Pharm. Chem. Life sci. (2/2014).

Clinical Trials [3081 Associated Clinical Trials listed on BioPortfolio]

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

This open-label, Phase I study will evaluate the safety, tolerability, and pharm acokinetics of increasing doses of GDC-0853 in patients with relapsed or refract ory B-cell non-Hodgkin's l...

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Belotecan (Camtobell, CKD-602, Chong Kun Dang Pharm., Korea) is a new camptothecin derivative, that exhibits anticancer effects by inhibiting topoisomerase I. The investigators will have a...

Comparison Study of Intravenous (IV) Versus Oral Iron (Fe) for Iron Deficiency Anemia Treatment in Late Pregnancy

The purpose of this study is to compare the efficacy of treatment between intravenous iron sucrose and oral iron fumarate in pregnant women in the third trimester.

Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia

This study will compare the effectiveness of three treatments in improving medication adherence, symptoms, and function in people with schizophrenia.

A Study for Patients With Non-Hodgkin's Lymphomas

In this study, all patients will get investigational drug. There will be no comparator drug. This study will evaluate three tumor types: T-cell lymphoma, Indolent B-cell lymphoma, and A...

Companies [883 Associated Companies listed on BioPortfolio]

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

cell pharm GmbH


Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...


Pharm-Chem.com is a special directory of the chemical and medicine industries, offering up-to-date information of China chemical and medicine manufacturers and suppliers as well as the news and the la...

Pharm PlanNet Contract Research GmbH

Pharm PlanNet Contract Research GmbH (Pharm PlanNet) was founded in 1992 as an independent and privately owned Clinical Research Organisation offering its service to the pharmaceutical industry. Pharm...

More Information about "cell pharm GmbH" on BioPortfolio

We have published hundreds of cell pharm GmbH news stories on BioPortfolio along with dozens of cell pharm GmbH Clinical Trials and PubMed Articles about cell pharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of cell pharm GmbH Companies in our database. You can also find out about relevant cell pharm GmbH Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record